Gemtuzumab ozogamicin 5mg powder for solution for infusion vials
in short Gemtuzumab ozogamicin 5mg inf vials
previously Gemtuzumab 5mg powder for solution for infusion vials
- SNOMED code
32761211000001103- Named
- Active compound
- Gemtuzumab ozogamicin
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Gemtuzumab ozogamicin
— 5 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Mylotarg 5mg powder for concentrate for solution for infusion vials (Pfizer Ltd)
in short Mylotarg 5mg pdr for concentrate for inf vials
previously Mylotarg 5mg powder for solution for infusion vials
Mylotarg 5mg powder for concentrate for solution for infusion vials
- SNOMED code
32761411000001104- Named
- Supplier
- Pfizer Ltd
- Licensed as
- Medicines - MHRA/EMA
- Earlier licensed as
- None
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Mylotarg 5mg powder for concentrate for solution for infusion vials (Pfizer Ltd) 1 vial32761511000001100 ref. pack | 💯 Available Legal category: POM | 50134570122485415062371763 | NHS Indicative Price £6,300 | • Hospital |
| — |
Reference packs
Gemtuzumab ozogamicin 5mg powder for solution for infusion vials 1 vial
- SNOMED code
32761311000001106- Quantity and unit
- 1 vial
- Packs